Signal-targeted therapies and resistance

Time	Event
09:05 - 09:30	Welcome of participants (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France)
09:30 - 09:35	Introduction from the Directors (Pierre Fabre's Center for Research and Development, Auditorium) - Gilles FAVRE (Cancer Research Center of Toulouse, Toulouse, France), Christian FILAQUIER (Pierre Fabre's Center for R&D, Toulouse, France)
09:35 - 10:20	mTOR signalling & metabolism (Pierre Fabre's Center for Research and Development, Auditorium) - Arkaitz CARRACEDO (CIC bioGUNE, Bilbao, Spain)
10:20 - 11:05	p110delta PI3K regulates gut immunity and inflammation by unconventional autophagy (Pierre Fabre's Center for Research and Development, Auditorium) - Ezra AKSOY (William Harvey Institute, London, United Kingdom)
11:05 - 11:25	Short talk 1 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined
11:25 - 11:55	Coffee break (Pierre Fabre's Center for Research and Development, reception lobby)
11:55 - 12:15	Short talk 2 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined
12:15 - 13:00	Synthetic Lethality screening identify ATR to synergize with oxaliplatin treatment in colorectal cancer (Pierre Fabre's Center for Research and Development, Auditorium) - Celine GONGORA (Institute of Cancer Research of Montpellier, Montpellier, France)
13:00 - 13:15	Participants go to CRCT for lunch & poster session - All participants will be led from the Pierre Fabre's Center for R&D to the CRCT
13:15 - 14:30	Lunch & Poster session (Cancer Research Center of Toulouse, meeting-room Christophe Cazaux)
14:30 - 14:45	Participants go to Pierre Fabre's Center for R&D for afternoon conferences - All participants will be led from the CRCT to the Pierre Fabre's Center for R&D
14:45 - 15:05	Short talk 3 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined
15:05 - 15:25	Short talk 4 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined
15:25 - 16:10	Loss of PI3K-C2alpha in breast cancer leads to genomic instability but increases Taxane sensitivity (Pierre Fabre's Center for Research and Development, Auditorium) - Emilio HIRSCH (University of Torino, Torino, Italy)
16:10 - 16:20	Conclusion & take-home messages (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France)

09:05 - 09:30

Welcome of participants (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France)

09:30 - 09:35

Introduction from the Directors (Pierre Fabre's Center for Research and Development, Auditorium) - Gilles FAVRE (Cancer Research Center of Toulouse, Toulouse, France), Christian FILAQUIER (Pierre Fabre's Center for R&D, Toulouse, France)

09:35 - 10:20

mTOR signalling & metabolism (Pierre Fabre's Center for Research and Development, Auditorium) - Arkaitz CARRACEDO (CIC bioGUNE, Bilbao, Spain)

10:20 - 11:05

p110delta PI3K regulates gut immunity and inflammation by unconventional autophagy (Pierre Fabre's Center for Research and Development, Auditorium) - Ezra AKSOY (William Harvey Institute, London, United Kingdom)

11:05 - 11:25

Short talk 1 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined

11:25 - 11:55

Coffee break (Pierre Fabre's Center for Research and Development, reception lobby)

11:55 - 12:15

Short talk 2 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined

12:15 - 13:00

Synthetic Lethality screening identify ATR to synergize with oxaliplatin treatment in colorectal cancer (Pierre Fabre's Center for Research and Development, Auditorium) - Celine GONGORA (Institute of Cancer Research of Montpellier, Montpellier, France)

13:00 - 13:15

Participants go to CRCT for lunch & poster session - All participants will be led from the Pierre Fabre's Center for R&D to the CRCT

13:15 - 14:30

Lunch & Poster session (Cancer Research Center of Toulouse, meeting-room Christophe Cazaux)

14:30 - 14:45

Participants go to Pierre Fabre's Center for R&D for afternoon conferences - All participants will be led from the CRCT to the Pierre Fabre's Center for R&D

14:45 - 15:05

Short talk 3 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined

15:05 - 15:25

Short talk 4 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined

15:25 - 16:10

Loss of PI3K-C2alpha in breast cancer leads to genomic instability but increases Taxane sensitivity (Pierre Fabre's Center for Research and Development, Auditorium) - Emilio HIRSCH (University of Torino, Torino, Italy)

16:10 - 16:20

Conclusion & take-home messages (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France)